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Psychosocial distress is reported as being quite prevalent, yet no standardized tool has 
been universally accepted to screen for distress.  Many tools have been created and 
validated for use to detect various components of distress, such as anxiety, depression, 
coping, and others.  The objective of this narrative literature review was to assess the 
state of screening for psychological/psychosocial distress in oncology and in the broader 
context of adult patient populations with medical diagnoses, compare the National 
Comprehensive Cancer Network Distress Thermometer Tool with two other common 
tools currently in use, and to elaborate on themes that were discovered in reviewing the 
literature.  Literature reviews were performed to explore the state of psychosocial distress 
screening implementation within oncology, assess for psychometric tools that are being 
utilized in adult patient populations in other disciplines and to select two common tools to 
compare with the Distress Thermometer.  A total of four literature searches were 
completed for this integrative review.  The Hospital Anxiety and Depression Scale and 
the Patient Health Questionnaire were found to be common in the literature, and were 
selected for comparison.  The three screening tools were found to be as effective in 
screening for distress, specifically anxiety and depression, though the Distress 
Thermometer was found to be inadequate to diagnose psychiatric disorders when present.  
Themes within the literature included: psychosocial factors bear influence on outcomes 
and should be assessed, lack of standardization in screening practices is evident, short 
tools, like those evaluated in this review, are best utilized as an initial assessment to guide 
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In 1999, the National Comprehensive Cancer Network (NCCN), a network 
comprised of the world’s top 27 institutions in cancer treatment, identified psychological 
stress as a crucial component needing to be addressed as part of the treatment plan.  The 
NCCN defined distress as, “a multifactorial unpleasant emotional experience of a 
psychological (ie, cognitive, behavioral, emotional), social, and/or spiritual nature that 
may interfere with the ability to cope effectively with cancer, its physical symptoms, and 
its treatment. Distress extends along a continuum, ranging from common normal feelings 
of vulnerability, sadness, and fears to problems that can become disabling, such as 
depression, anxiety, panic, social isolation, and existential and spiritual crisis” (Holland 
et al., 2016, p. DIS-3).  The term distress was chosen by the committee, as there is less 
association with more stigmatizing, connotations that words, like: emotional, 
psychologic, and stress tend to convey.  Utilization of the term tends to mitigate any 
negative feelings or embarrassment that could otherwise be provoked from the patient’s 
perspective by other terms.  Another benefit is that it is assessable via direct report from 
the patient (Holland et al., 2016, p. DIS-1).  It has been determined that reducing patient 
distress improves quality of life, promotes healing and may even lead to better patient 
outcomes (Pirl et al., 2014). 
Assessment for distress/stress in the form of anxiety and depression screening, 
and as a component of assessing quality of life (QoL), is gaining momentum throughout 
the many disciplines of healthcare.  The effects of psychosocial/psychologic stress have 
been shown to contribute to less than optimal outcomes from decreased medication 
2 
adherence (Crawshaw, et al., 2016), psychosomatic comorbidity (Loughman, et al., 
2016), and increased mortality (Russ, et al., 2012); yet there is no clear universal 
standardized assessment tool.  This has resulted in the creation of many psychometric 
assessment tools aimed at identifying and addressing various aspects of psychosocial 
distress.  One systematic review identified 33 psychometric tools in a variety of contexts 
(Vodermaier, Linden, & Siu, 2009).  Instruments such as the Hospital Anxiety and 
Depression Scale (HADS), Patient Health Questionnaire-9 (PHQ-9), Beck Depression 
Inventory (BDI), and others, are used to determine a specific aspect of psychosocial or 
psychologic distress and predict impact on QoL and illness burden.  Often, the focus is 
directed toward specific domain(s) of psychosocial health, such as, anxiety, depression, 
or coping, effectively limiting the information gleaned from assessment by narrowing the 
definition of distress to a specific component. 
Within the oncology setting, screening for psychosocial distress using a validated 
screening tool, specifically, the National Comprehensive Cancer Network Distress 
Thermometer (DT) and associated problem list, has been part of oncology treatment 
guidelines since 1999 (Holland, 1999).  In spite of the availability of an oncology-
specific tool, a variety of tools are still being utilized to screen for the various 
components of psychosocial well-being (Mitchell, Meader, & Symonds, 2010; 
Vodermaier & Millman, 2009; Nelson et al., 2016; Andersen et al., 2014). 
Problem Statement 
It is reported that greater than one-third of cancer patients experience significant 
levels of distress, and it is known that levels of distress increase with advancing illness 
(Holland & Bultz, 2007; Pirl, et al., 2013).  A cancer diagnosis affects entire families and 
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can exert a tremendous burden on QoL.  The American College of Surgeons Commission 
on Cancer (CoC) (2016) standards require that distress screening be part of the 
assessment process for every patient as one aspect of criteria for accreditation (Pirl et al., 
2013).  Though awareness of inadequate recognition of distress in cancer patients has 
been apparent since at least 2001, insufficient screening procedures continue to be 
identified as a barrier to provide adequate psychosocial care for patients who may need it, 
and implementation of screening programs is not standardized across treatment centers 
(Brown, 2014; Fallowfield, Ratcliffe, Jenkins, & Saul, 2001; Holland et al., 2013; 
Holland et al., 2016; Zucca et al., 2015).  Routine screening and appropriate referral has 
been shown to improve QoL in groups known to experience high levels of distress (Bultz 
et al., 2013; Pirl, et al., 2013).  Failure of the treatment team to adequately screen, assess, 
refer, and provide resources to mitigate the high levels of distress associated with cancer 
diagnosis and treatment impairs the ability of the patient to heal in the most effective and 
efficient manner (Bauwens, Baillon, Distelmans, & Theuns, 2014). 
Purpose Statement 
The purpose of this narrative literature review was to assess the state of screening 
for psychological/psychosocial distress in oncology settings and in the broader context of 
adult patient populations with medical diagnoses.  The DT is qualitatively compared with 
two other common psychometric assessment tools identified in the literature review.  
Themes discovered in the use of these common tools are presented.   This review serves 
as a call for future and continued research to develop best practices regarding screening 
for psychosocial distress, and contributes to increased awareness of the need to include 
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psychosocial distress screening and management in the plan of care beyond outpatient 
oncology settings to include inpatient areas and disciplines beyond oncology as well. 
In addition, this narrative literature review provides a summation of the state of 
distress screening in cancer care and a qualitative comparison between the DT and two 
common psychometric tools that are utilized both inside and outside the discipline of 
oncology. Finally, it is this author’s hope that this review increases awareness of the 
importance of addressing the psychosocial needs, increases research efforts toward the 
development of best practices, and encourages implementation of distress screening in 





Review of the Literature 
In order to meet the purpose of this narrative review, three separate literature 
reviews were conducted.  The first assesses the state of screening for 
psychological/psychosocial distress in oncology settings.  The second examines in the 
broader context of screening stress/distress in adult patient populations with medical 
diagnoses. Finally, the two most prevalent instruments in the literature will be identified 
for further comparison with the identified oncology distress screening tool.  
Psychosocial Distress Screening in Oncology Settings 
An initial review of the literature for distress within the oncology setting was 
performed using CINAHL and PubMed databases and searching for the following 
keywords: neoplasms, cancer, distress, screening, diagnosis, detection, early detection, 
mass screening, distress thermometer, and inpatient.  Sixteen applicable articles were 
found according to the following inclusion criteria: the subjects were cancer patients, the 
setting was oncology, the DT was used or referenced, implementation of the DT was 
addressed and focused upon its effect on cancer patients and clinicians who administer 
the screening.  Articles that focused on other areas of clinical practice or were not 
concentrated on the impact of implementation of screening were excluded.  NCCN 
guidelines, ACS Standards, and CoC Standards were also consulted.  Table 1 summarizes 
the articles included in the review.   
The literature shows that patterns of evidence supporting the need for screening, 
method of screening, screening tool utilized, and implementation process for screening 
are found to be overwhelmingly consistent with NCCN Guidelines for Distress 
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management (Bellè, Muzzatti, Tomas, & Gherlinzoni, 2016; Donovan & Jacobsen, 2013; 
Holland et al., 2013; Pirl, et al., 2013; Jacobsen & Ransom, 2007; Wagner, Spiegel, & 
Pearman, 2013; Zebrack, Burg, & Vaitones, 2012).  These studies also reference the ACS 
verbiage of screening patients during a pivotal medical visit, which is generally defined 
as a visit in which a diagnosis is communicated, a change in treatment occurs, or 
treatment is ended (Pirl et al., 2014; Wagner et al., 2013).  NCCN member institutions 
reported an increase in routine screening from 53% in 2007 to 70% in 2013, though the 
majority of screening still occurs almost exclusively in the outpatient setting (Donovan & 
Jacobsen, 2013; Jacobsen & Ransom, 2007).  In the outpatient setting as well, screening 
is done without discernible consistency.  Zebrack et al. (2015) reported that in the two 
sites that were examined, only 43% to 73% of patients who met screening criteria were 
actually screened.  Furthermore, appropriate referral was made and documented only 
50% to 63% of the time.   
The issue of optimal frequency of screening and screening in the inpatient settings 
is extremely limited in the literature.  Only one study (Hess et al., 2015), was found to 
have researched optimal frequency for screening, and was focused on the outpatient 
setting.  This study concluded that screening bimonthly led to a 90% identification rate of 
referable distress in oncology patients receiving radiation.  Only three recent studies were 
found that addressed distress screening in an inpatient setting specifically.  One 
experimental design study (Hermelink et al., 2014) (n = 125) reported an increase in the 
acceptance of psychosocial resources compared with similar studies done on outpatient 
subjects, indicating higher levels of distress among hospitalized patients.  Bellè et al. 
(2016) (n = 105) described consistency in distress with NCCN reported values, and that 
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24.5% of all patients who were screened reported distress in all four problem area 
domains – practical, relational, emotional, and physical.  The third study conducted by 
Wang et al. (2011) (n = 103) reported that the DT was a suitable assessment tool for 
anxiety and depression in hospitalized Taiwanese patients with cancer.  The probable 
increase in distress in hospitalized cancer patients, as reported in these studies, should 
lend to increased interest in distress screening implementation in an understudied patient 
population.  Interestingly, no correlation between increased distress and patient 
psychological adjustment to diagnosis was noted (Constantini et al., 2015).  The literature 
also shows that barriers common to the implementation of routine screening are mostly 
attributed to clinician perception of inadequate resources, availability and efficiency of 
oncology social workers, amount of time screening protocols have been in place, lack of 
clarity and education in the implementation process, lack of privacy for screening, and 
failing to customize the screening program to the appropriate setting (Carolan & 
Campbell, 2015; Chiang, 2015; Hess et al., 2015; Lazenby, 2014; Zebrack 2015).  
However, one study reported that after screening measures had been implemented, 
facilitator and clinician perspectives were overwhelmingly positive, with nearly 70% 
reporting that the instrument was user-friendly, that their workload was not negatively 
impacted, and that screening should continue (Hammelef et al., 2014). A thematic 
overview of the literature follows. 
Distress screening was proposed as an integral part of routine cancer care in 1999 
via the introduction of it into the NCCN Clinical Practice Guidelines (Holland, 1999).  
Although several tools have been validated for use with cancer patients the NCCN 
guidelines recommend the use of the DT, which consists of a thermometer with a 1to 10 
8 
analogue scale and a problem list.  The problem list consists of four main categories, or 
domains, of distress; these are: practical problems, family problems, emotional problems, 
and physical problems.  A free text space to allow the patient to report spiritual or 
religious concerns, or anything not otherwise listed, is also available (Holland et al., 
2016, p. DIS-A).  Each domain lists common sources of distress that are utilized to assist 
in making appropriate referrals (Tavernier, 2014).  The guidelines also identify risk 
factors and periods of increased vulnerability for high levels of distress (Holland et al., 
2016, p. DIS-B).  The DT has been validated for use all over the world, in more than 18 
languages (Donovan, Grassi, McGinty, Jacobsen, 2013).  The DT and associated 
guidelines provide a validated, objective tool for assessment of psychosocial distress in 
cancer patients.   
In addition to the NCCN, distress screening was endorsed and adopted into the 
Program Standards by the Commission on Cancer (CoC) of the American College of 
Surgeons (ACS), mandating that patients be screened a minimum of one time during a 
“pivotal medical visit” (ACS, 2014; Brown, 2014; Pirl et al., 2014).  The pivotal medical 
visit has been traditionally interpreted to mean at diagnosis or at a point of significant 
change in treatment (Brown, 2014). The 2016 edition of the CoC practice standards 
define the pivotal medical visits more fully, broadening to multiple encounters and 
defining them as, “times of greatest risk for distress, such as at time of diagnosis, 
transitions during treatment (such as from chemotherapy to radiation therapy), or 
transitions off treatment” (ACS, 2016, p 56).  Examples of pivotal visits included in the 
practice standard are, “postsurgical visits, first visit with a medical oncologist to discuss 
chemotherapy, routine visit with a radiation oncologist, or a post chemotherapy follow-up 
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visit” (ACS, 2016, P 56).  Though admission to the hospital is not mentioned in the above 
list, the criteria for what constitutes a pivotal visit as well as the periods of increased 
vulnerability presented by the NCCN guidelines are directly applicable to an acute care 
admission to the hospital.  These include: change in treatment modality, significant 
treatment-related complications, discharge from hospital following treatment, treatment 
failure, progression/recurrence, etc., admission to an acute care environment is not 
mentioned by either committee (ACS, 2016; Holland et al., 2016, p. DIS-B).  The idea of 
assessing for distress at a pivotal medical visit has resulted in inconsistent, and sometimes 
absent, screening practices that fail to adequately identify at risk patients through the full 
spectrum of the continuum of care (Pirl et al., 2013).  Several authors recommend a much 
more systematic implementation of the distress management guidelines, at times, 
invoking distress screening as “the sixth vital sign” (Brown, 2014; Bultz, et al., 2013; 
Holland & Bultz, 2007; Lazenby et al., 2015; Pirl et al., 2014).  Cancer centers are 
currently working to implement these new guidelines, yet, that effort remains focused 
almost entirely on outpatient care settings.   
Review of the Literature: Psychosocial Screening Tools in Other Disciplines 
A literature review for systematic reviews identifying psychometric assessment 
tools outside of the oncology context was performed using PubMed and CINAHL 
databases from September 2008 to July 2017.  The search for full text reviews in English 
returned 3,087 initial sources.  Titles were screened and eliminated based on the 
exclusion criteria as follows: duplicate, cancer-related, applicable to healthcare workers 
and not patients, applicable to school or education, population was pediatric, population 
was psychiatric and not medical, no medical diagnosis was associated with the screening, 
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or no assessment tool was identified.  After exclusions by article title and duplication, 
141 article abstracts were reviewed, and 61 were eliminated based upon the criteria 
above.  The remaining 77 full text articles were reviewed.  Of these, 35 articles presented 
psychometric screening tools.  Upon further examination, it was determined by this 
author that QoL is a larger concept that often includes psychosocial and psychologic 
distress, but does not evaluate it.  Articles focusing on QoL without specific referral to 
patient stress or distress were also eliminated, leaving 15 articles for review.   
Prevalence of Psychometric Tools 
Psychometric tools (see Table 2) were listed and cross-referenced with the 
systematic review of assessment instruments by Vodermaier, Linden, and Siu (2009), to 
determine if any novel tools have been reported in the literature since the researchers 
performed their review.  No novel tools were found in that effort.  The list of tools was 
reviewed to identify which tools appeared frequently.  HADS, appearing in 8 of the 15 
reviews, and PHQ-9 also appearing in 8 of the 15 reviews. 
Hospital Anxiety and Depression Scale (HADS) 
HADS was introduced in 1983 in order to fill a need for brief self-assessment of 
mood apart from the psychiatric setting, and also to provide more information as to the 
nature of the psychologic issue (Zigmond & Snaith, 1983).  The authors chose the two 
most prevalent metrics affecting hospitalized patients: anxiety and depression.  Since 
then, the HADS has been validated in many other contexts, including in psychosocial 
assessment of cancer patients, and is well-established as a valid measure for anxiety and 
depression (Vodermaier & Millmann, 2011; Vodermaier, Linden, & Siu, 2009; Bjelland, 
Dahl, Huang, & Neckelmann, 2002; Herrmann, 1997).  It has been considered the most 
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widely researched and validated mood scale in medical settings, including oncology and 
palliative care (Mitchell, Meader, & Symonds, 2010). 
The HADS consists of 14 questions that assess aspects of either anxiety or 
depression.  Each answer is assigned a numeric value.  Each subscale (anxiety or 
depression) has a possible range of 0 to 21.  Once the assessment is completed, the totals 
for each question type are tallied.  In general, a subscale score of 7 to 8 is considered a 
possible case, 10 to 11 is considered a probable case, and 14 to 15 is considered a severe 
case (Zigmond & Snaith, 1983).  No official cutoff score was determined, until 2002, 
when an updated review performed a receiver operating characteristic (ROC) analysis to 
determine that ≥8 is the optimal cut-off for both subscales (Bjelland, et al. 2002).  Despite 
some early concern about its length, the HADS is easy to complete, and is generally well-
received by patients (Herrmann, 1997; Mitchell et al., 2010).  The HADS is widely 
regarded and recommended as a tool for initial screening for presence of anxiety and 
depression, but is not validated for diagnosis of psychiatric disorders when compared 
with diagnostic clinical interviews (Mitchell et al., 2010; Schellekens et al., 2016) 
The Patient Health Questionnaire (PHQ)  
The Primary Care Evaluation of Mental Disorders (PRIME-MD) was developed 
by Spitzer, Kroenke and Williams in the mid-1990s gave rise to the development of the 
PHQ.  Evaluation of the PRIME-MD determined that the instrument was too 
cumbersome due to the length (25 questions), the requirement of clinician administration, 
and time needed to complete the assessment – it was reported to take approximately 8.4 
minutes to complete.  Due to lack of use, the researchers developed and introduced in 
1999 the PHQ (Spitzer, Kroenke & Williams, 1999).  In the initial study of 3,000 adult 
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patients from eight different clinical sites, Spitzer et al. (1999) found not only did the 
PHQ perform as well as the PRIME-MD, but also assisted the provider in recognizing 
hundreds of patients who would not have been diagnosed correctly with a mood disorder.  
Eighty percent of providers reported finding value in this new tool, and 88% of patients 
reported comfort in completing the assessment.  The PHQ was found to be able to detect 
depression at a diagnosable level in less than one minute in most cases. 
Since that initial study of the PHQ, several versions (corresponding mostly to the 
number of questions) have been developed.  The PHQ-9, a nine-question diagnostic 
assessment, is esteemed as “the most validated tool in mental health,” as a gold standard 
assessment (Aims Center, 2017; Hegel et al., 2008).  It has been validated in general 
practice settings all over the world, from China to Somalia to Haiti and beyond (Chen et 
al., 2010; Marc et al., 2014; Nallusamy, Afgarshe, & Shlosser, 2016).  It is versatile; able 
to be administered in a variety of contexts and age groups (Aims Center, 2017).  The nine 
questions on the PHQ-9 correspond to the nine symptoms of major depression as 
presented in the Diagnostic and Statistical Manual of Mental Disorders, namely: 
Depressed mood,  diminished interest or perceived decreased pleasure, significant 
unintentional weight change of more than 5% of body weight in a month, insomnia or 
hypersomnia, physical slowness or being fidgety, fatigue, feelings of worthlessness or 
guilt, difficulty concentrating or making decisions, and suicidal ideation (Reynolds, & 
Kamphaus, 2013).  PHQ has been validated in a few other versions.  The PHQ-2, is an 
ultra-brief, two-question, depression screening tool that was introduced in 2005 (Lӧwe, 
Kroenke, & Grӓfe, 2005).  In this assessment, the first two questions of the PHQ-9 are 
given.  If both questions are screened positive for depression, then the rest of the PHQ-9 
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is administered (Hegel et al., 2008).  The PHQ-4, introduced in 2009, assesses for 
depression and anxiety (Kroenke, Spitzer, Williams, & Lӧwe, 2009). Finally, the PHQ-8 
is used in the general population as a valid diagnostic measure for current depression 




Comparison of Assessment Tools 
A narrative review is defined by Polit and Beck (2012) as a common form of a 
systematic review.  It is a way to gather evidence on a specific topic for synthesis.  The 
purpose of this narrative literature review was to assess the state of screening for 
psychological/psychosocial distress in oncology settings and in the broader context of 
adult patient populations with medical diagnoses.  This information was detailed in 
Chapter II of this study.  This narrative literature review provides a summation of the 
state of distress screening in cancer care and although several tools have been validated 
for use, the NCCN guidelines recommend the use of the Distress Thermometer (DT).  In 
the methods section a qualitative comparison between the DT and two common 
psychometric tools (Hospital Anxiety and Depression Scale [HADS] and the nine item 
Patient Health Questionnaire [PHQ-9]) that are utilized both inside and outside the 
discipline of oncology is presented.  
Comparison of the DT to HADS 
An additional search of PubMed and CINAHL databases was conducted for Full 
text articles in English, in which the subjects were adults (age 19 and above) using search 
terms, "Hospital Anxiety and Depression Scale" and "Distress Thermometer.”  The 
search for a comparison between HADS and the DT yielded 103 results.  After reviewing 
titles and removing duplicates, 65 articles remained.  Abstracts and full texts were 
reviewed to include only articles that compared HADS and the DT.  There were 7 articles 
found that met these criteria (see table 3). 
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HADS and the DT performed similarly to detect anxiety with an average 
sensitivity of 74.42% and a specificity of 71.98% (Bidstrup et al, 2012; Boyes et al., 
2013; Lambert et al., 2014; Schellekens, 2016).  Wang et al. (2011) found that the DT 
outperformed HADS (DT cut-off ≥4, sensitivity 98% and specificity 72% compared with 
HADS ≥9, sensitivity 84% and specificity 73%) in a sample of 103 hospitalized cancer 
patients.  Though both HADS and the DT are suitable for screening for general distress, 
including anxiety and depression, neither tool was recommended for screening of 
psychiatric disorders specifically, provoking the recommendation that in the case of 
screening for psychiatric disorders, follow up diagnostic interviews are preferred 
(Schellekens et al, 2016).  HADS was reported to identify psychiatric disorders slightly 
better than the DT, and was recommended as a follow-up assessment to the DT (Lambert 
et al., 2014).  In another study Butow et al. (2012) reported that the DT showed better 
anatomical association to known areas of brain activity with regard to response to stress 
than HADS.  Optimal cut-off scores for the DT were variable, depending upon the setting 
(Boyes et al., 2012). 
Comparison of the DT to PHQ 
An additional search of PubMed and CINAHL databases was conducted for full 
text articles in English, in which the subjects were adults (age 19 and above) using search 
terms, “PHQ” AND "Distress Thermometer."  The search for the comparison between 
PHQ and the DT yielded 19 results.  After reviewing titles and removing duplicates, 7 
articles remained.  Abstracts and full texts were reviewed to include only articles that 
compared PHQ and the DT.  There were 4 articles found that met these criteria (see table 
4). 
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There is some heterogeneity with regard to the literature comparing the DT and 
PHQ.  The DT was found to detect depression and perception of need for resources or 
referral as well as PHQ in three of the four studies reviewed (Faller et al., 2016; Hegel et 
al., 2008; Lazenby, Dixon, Bai, & McCorkle, 2014).  One study reported a large 
difference in sensitivity between the DT, 92%, and PHQ-2, 32%, in a study of 123 newly 
diagnosed cancer patients (Lazenby et al., 2014).  These authors found consistency 
between the DT and PHQ-9, detecting 39 more cases of depression than PHQ-2.  This 
result is contradicted in a larger study of 455 participants, which found the DT to be less 
accurate than PHQ, with a DT sensitivity of 80% and a specificity of 52%, compared 
with average PHQ specificities of 82.5% and 66% (Wagner et al., 2017).  In a study of 
321 patients newly diagnosed with breast cancer, the DT was found to be comparable 
with PHQ, though, like comparisons with HADS, the authors recommend that a positive 
screen may require follow-up with a more focused assessment (Hegel et al., 2008).  The 
largest study, with 4,020 patients, found that the DT, PHQ-2 and PHQ-9 performed 






The purpose of this narrative literature review was to assess the state of screening 
for psychological/psychosocial distress in oncology settings and in the broader context of 
adult patient populations with medical diagnoses.  The Distress Thermometer (DT) was 
qualitatively compared with the Hospital Anxiety and Depression Scale (HADS) and the 
Patient Health Questionnaire (PHQ); common psychometric assessment tools identified 
in the literature review.  Themes discovered in the use of these common tools are 
presented.    
Multiple literature searches were conducted during this narrative inquiry.  This 
research identified three of the most common instruments (DT, HADS, and PHQ) used in 
the assessment of stress, distress, and anxiety.  Comparisons of those three were made.  
Commonalities or themes were found throughout the literature review and designated by 
this author to include: psychosocial factors bear influence on outcomes and should be 
assessed, there is  lack of standardization in how to screen and assess for psychosocial 
factors across several chronic illness states, tools like the DT are best utilized as a brief 
screen to gain a broad view of psychosocial factors leading to a determination regarding 
which focused tool might be used to provide referral or treatment, and finally, that short 
assessments are well-tolerated by patients and effective for detecting psychosocial 
factors. 
Approximately one-third of all cancer patients experience distress that is 
significant enough to require psychological and psychosocial support (Faller et al., 2016; 
Hegel et al., 2008).  Anxiety and/or depression as a component of distress is assumed or 
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directly stated throughout the literature, and is evidenced by the prevalent use of tools 
that target anxiety and depression to screen for distress (Boyes et al., 2013; Lazenby et 
al., 2014; Wang et al., 2011).  It has been reported that as many as 24% of cancer patients 
may experience depression, and that depression has been associated with an increase in 
mortality compared with patients who experience less or no depression (Wagner et al, 
2017).  High rates of depression are also noted in other patient populations, such as HIV, 
chronic pain, cardiovascular disease, and other chronic illnesses (Dansie & Turk, 2013; 
Lai, Yew, Kennedy, & Schwartz, 2016; Van der Heijden et al., 2017).  Distress in the 
form of anxiety and depression has also been associated with decreased overall quality of 
life, increased physical symptoms, increased reported pain and fatigue, treatment non-
adherence, and suicide (Crawshaw et al., 2016; Croicu, Chwastiak, & Katon, 2014; 
Dansie & Turk, 2013; Feinstein et al., 2014; Van der Heijdan et al., 2017). 
The sheer number of psychometric screening tools uncovered in this narrative 
literature review underline the lack of standardization of screening, in spite of 
overwhelming recommendations that such screening be performed as an integral part of 
the plan of care (see Table 2).  Reasons offered for this are that clinicians often lack 
proper education to administer screening tools and psychometric assessments accurately, 
reported perceptions of lack of time, or appropriate level of privacy for assessment, and 
perceived inability to provide adequate follow-up and resources should psychosocial 
factors be detected (Butow et al., 2015; Ferro, Caerio, & Figeria, 2016; Kyong Suk, 
2017).  One recommendation was to establish an evidence-based guideline for routine 
psychosocial screening for anxiety and depression.  This guideline recommends the 
development of clearly defined professional roles within the interdisciplinary team, 
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including a dedicated core of trained individuals who are able to recognize signs of 
anxiety and depression and are empowered to implement screening procedures as needed.  
Two-step screening, with the DT or a similar screening tool, and follow-up with HADS 
or another more focused tool is recommended.  If screening yields a positive result, then 
referral for a more in-depth assessment should be made.  Treatment will follow a 
stepwise approach of intervention intensity (Butow et al., 2015). 
Focused screening tools, like HADS and PHQ-9, do not, and are not intended to, 
capture psychosocial distress outside of anxiety and depression.  Due to this known 
limitation, the recommendation that initial screening with a broader tool, such as the DT 
and associated problem list and subsequent follow-up with a more specific tool or referral 
is often presented in the literature (Bellè et al., 2016; Butow et al., 2015; Lambert et al., 
2014; Schellekens et al., 2016).   
Finally, patients liked the DT and similar short assessments.  None of the studies 
reviewed reported significant burden or participant refusal to complete assessments, or 
that a significant number of incomplete assessments were submitted, indicating that the 




Chapter V: Discussion 
Limitations 
Limitations of this narrative literature review include the complex, multivariable 
nature of the patient population and disciplines investigated, lack of standardization in 
screening across disciplines, large number of survey and screening tools that can be used, 
and differing definitions of stress or distress. 
Implications for Nursing Practice 
Nurses are a key component of the treatment team.  As psychosocial distress 
assessment becomes more a standard of care, nurses will very likely be integral in the 
implementation of screening and making appropriate referrals in a variety of contexts.    
Psychosocial factors contribute to a wide array of psychiatric, somatic, and quality of life 
measures, but no one standardized tool universally addresses these completely.  Anxiety 
and depression are overwhelmingly recognized as key factors that must be addressed 
regardless of discipline.  The DT has been shown to be as effective at detecting anxiety 
and depression in cancer patients, and has begun to gain traction in other disciplines as 
well.  The DT and associated problem list serves a good starting point to determine which 
psychosocial factors need to be addressed by the treatment team.  More focused 
assessment tools, like the HADS, PHQ-9, and others, are useful as follow-up assessments 
that can guide the treatment of psychosocial factors and potential diagnosis of psychiatric 
disorders.  Tools, like the DT, can be implemented by nurses at the bedside with minimal 
impact on workflow or workload for the purpose of addressing psychosocial factors in 
the continuum of care. 
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Conclusion and Recommendations 
Implementation of screening procedures requires standardization.  As seen in this 
literature review, when screening measures are implemented in oncology, tools intended 
to assess for anxiety and/or depression are common.  These may not provide adequate 
referral to needed resources for cancer patients, as they are limited within the scope of the 
purpose of the assessment.  The DT explores assessment through a broader lens that 
exceeds the limits of depression and anxiety, and is a valid tool when compared to gold 
standard scales, like HADS and PHQ.  When depression and/or anxiety are present, the 
DT has demonstrated the ability to detect it with a high degree of specificity and 
sensitivity.  Though the DT performs poorly as a diagnostic tool, it was never intended to 
be used as such.  Therefore, use of the DT as an initial screening tool to be followed up 
with the more focused assessment tools, such as HADS, PHQ-9, makes logical sense in 
the progression of first, identifying the psychosocial element or elements causing distress 
to assessing the severity with more focused tools, and finally treating based on the 
assessment information.  As the implementation of psychosocial assessment become 
more common, the DT could play an important role in expanding its use from outpatient 
oncology settings to include inpatient environments and to various disciplines outside of 
the confines of oncology. 
Further research to determine the validity of screening for psychosocial factors in 
the inpatient setting is needed.  Distress screening in the inpatient setting may have 
significant value for capturing the need for referral to resources and lowering overall 
distress levels among cancer patients and those with chronic medical illness, especially as 
the acute episode that warranted admission resolves.  Further, inclusion of the inpatient 
22 
setting can contribute to the recommendation for more systematic approaches to distress 
screening in cancer care in general, providing for fluidity and continual assessment 
throughout the continuum of care. 
This review serves as a call for future and continued research to develop best 
practices regarding screening for psychosocial distress, and contributes to increased 
awareness of the need to include psychosocial distress screening and management in the 
plan of care beyond outpatient oncology settings to include inpatient areas and disciplines 
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Summary of NCCN-DT Implementation Literature 
 
Study Purpose Method/Tool Results Notes 
Bellè et al., 
2016 
Utilize and assess NCCN DT in 
hematologic inpatient 
population 
Administered DT and problem list 
(n=102) 
 
41.6% reported distress unrelated to 
diagnoses of sex. 
12.9% reported sever distress.  Top 
three mean reported sources of 
distress (from problem list) were: 




assessed with one 
screening tool.  One of 
three focused on distress 




Explore clinician perspective of 
psychosocial distress screening 
in cancer patients 
A sample of 7 general practitioners 
(GPs) were interviewed regarding 
their experience and attitudes toward 
screening for psychosocial distress in 
cancer patients 
 
assessing for distress was seen as a 
process of multiple hand-offs, much 
like a relay race, between GPs and the 
rest of the interdisciplinary treatment 
team.  Themes identified were:  
 Relationship enhances assessment 
 GPs perceive they are good at 
screening 
 Assessment is challenged by 
barriers 
 Validated tools were not preferred 
 
Barriers that were 
identified included: GP 
attitudes and beliefs, time, 
patient reaction, beliefs, 
and values, and family.  
Family was also noted to 
be helpful at times, but a 
barrier at others. 
Constantini 
et al., 2015 
Examine patient awareness of 
cancer and relationship with 
care in regard to distress and 
satisfaction 
Visual analogue assessment scales for 
patient awareness; 
European tool (EORTC IN_PATSAT-
32) to assess patient satisfaction; 
Mini-mental Adjustment to Cancer 
scale to assess coping; 
NCCN DT used to assess distress 
level for the previous week. 
Analysis was two-tailed ANOVA and 
Chi-square or Fisher’s exact test 
 
Cancer awareness and psychological 
maladjustment were not related to 
distress 
Increased distress is not 
associated with 
knowledge of diagnosis, 
but more with the 
inference that information 
is being hidden from the 
patient. 
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Study Purpose Method/Tool Results Notes 
Chiang et 
al., 2015 
Improvement of screening 
processes and documentation 
Cause-and-effect analysis to discover 
barriers 
Screening of 864 cancer patients via 
paper and RN documentation in an 
electronic medical record (EMR) 
Barriers included: lack of time with 
patients, lack of resources, lack of 
privacy, and patients’ uneasiness with 
the assessment. 
62% of those assessed reported mild 
distress (DT 0-3), 18% moderate (DT 
4-6), and 11% severe (Dt 7-10) 
Over course of study, 
EMR documentation 
increased from 19.2% to 
34% 
New patients had higher 






Follow up on current 
implementation of distress 
management guidelines (7 
years after original study – see 
Jacobsen & Ransom, 2007) 
20/21 NCCN member institutions 
(91%) participated in a survey 
regarding implementation of screening 
procedure 
70% report routine screening 
25% report inpatient screening 
60% report outpatient screening 
50% screen all outpatients 
50% screen certain groups 
85% use a self-report tool 
59% use NCCN DT & problem list 
 
Between 2005 and 2012: 7% increase 
in routine screening; 10 % increase in 




increasing, but at a much 
lower rate in the inpatient 
setting 
Hess, et al., 
2015 
Assess optimal frequency for 
distress screening in outpatient 
radiation oncology patients 
Daily screening with NCCN DT, 
scores ≥4 were recorded. 
Prevalence data analyzed in interval 
periods along with clinical variables 
and trends 
37% reported distress 
 
No interval showed significance for 
adequate prediction of distress. 
 
Screening every other week identified 
distressed patients almost 90% 
 
Interval assessment may 
be more effective than 
risk assessment by 
variable 
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Study Purpose Method/Tool Results Notes 
Hammelef 
et al., 2014 
Conduct and evaluate a quality 
improvement initiative on the 
implementation of the NCCN 
distress management guidelines 
in an ambulatory oncology 
environment 
 
238 visits were screened in the 
experiment group, and 248 records 
were reviewed in the control group.  
Data was analyzed with multilinear 
regression. 
 
Clinical staff involved in the 
implementation and administration of 
screening were subsequently 
surveyed. 
Population mean was – DT 2.8 
31% reported moderate distress (DT 
4-7), and  7% reported severe distress 
(DT 8-10) 
59% of patients with a positive 
distress score (DT ≥4) received 
referrals, and was noted to be 
significantly higher than the control 
group review 
Approximately 70% of staff responses 
were favorable, indicating tool was 
user-friendly, that the use of it did not 
negatively impact their workflow, and 
recommended screening should 
continue. 
 
Patients acquiescence to 
complete screening 




et al., 2014 
Evaluation of brief distress 
screening in a breast and 
gynecologic cancer center 
NCCN DT used to screen hospitalized 
patients 
125 patients screened 
54.4% referred for counseling; 49.6% 
accepted referral 
4% self-referred 
65.8% reported significant benefit 
from counseling 
5.6% of non-counselled patients 





Majority of patients 





Assess state of implementation 
of distress management 
guidelines in NCCN Member 
Institutions 
83% of NCCN member institutions 
participated in a survey regarding 
implementation of screening 
procedure 
8% report routine screening 
27% pilot-testing strategies for 
screening 
37.5% of facilities that screen, use 
interviews 
Amount of use of DT unclear 
 
Implementation is elusive 
after 8 years of 




Study Purpose Method/Tool Results Notes 
Lazenby, 
2013 
International exploration of 
concept of distress screening as 
a “sixth vital sign” and provide 
a pathway for implementation 
of routine screening 
Synthesis of literature Lack of validated screening tool 
results in lack of recognition of 
distressed patients. Implementation in 
three phases: 
(evidence integration triangle): 
Identify stakeholders, allow adaptation 
to fit current practices, and employ 
measures to provide feedback and 
reinforcement of progress of 
implementation 
Pivotal visit as related to initiation of 
treatment is inadequate 
Team-oriented support and education 
is needed 
Frequency must be agreed upon and 
based upon times of greatest risk for 
distress 
 
Identifies need to increase 
frequency and scope of 
screening 
Pirl et al., 
2014 
Provide guidance on the 
implementation of screening of 
psychosocial distress in order to 
meet the ACS CoC mandate for 
screening in the 2015 
requirements for accreditation 
 
Review of the requirements of the new 
accreditation standard along with 
recommendations for implementation 
Recommendation is to screen at every 
encounter, using a tool that has been 
validated in cancer patients.  Among 
the tools listed are DT, HADS, PHQ, 
GHQ, PDI, and BSI. 
These authors place 
weight of meeting the 
standards with planning 






Evaluation of link of depression 
and outcomes in cancer 
patients, and influence of 
psychosocial care 
Screening of 562 patients over a 10-
month timeframe 
 
Referrals, based on positive screening, 
were messaged to social worker 
37% referred to social work for: 
Help managing stress (13%) 
Support group information (8%) 
Information from medical librarian 
(23%) 
 
Messages effectively identified 
patients with unmet psychosocial 
needs 
 
Authors expanded the 
screening asserting 
profound impact on 
cancer care 
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Study Purpose Method/Tool Results Notes 
Wang et 
al., 2011 
Validation of the DT in 
Taiwanese patients with cancer 
DT and HADS tools were used to 
assess a sample of 103 patients over a 
7-month period in 2004.  Cut-offs 
were determined as ≥4 for DT and  
≥ 8 for HADS subscales 
 
DT outperformed HADS in sensitivity 
and specificity, though either tool is 
appropriate to assess the target patient 
population 
One of the articles that 





Provide information and 
assistance in the 
implementation of distress 
screening toward meeting CoC 
2015 mandate 
Systematic review Authors recommend: 
Build a list of best practices that can 
be duplicated in various oncologic 
settings 
Develop standardized process for 
screening and referral 
Emphasize added value that patient 
receives to increase administrator buy-
in. 
 
Focus is on social worker 










Determine if there is variation 
in screening across Australian 
treatment centers in medical 
oncology 
Cross-section of outpatient medical 
oncology patients from six treatment 
centers; n = 716 
Difference for screening for symptoms 
and emotional distress was 
insignificant 
distress – p=0.65 
pain – p=0.21 
fatigue – p=0.95 
other – p=0.40 
Infrequent screening resulted in 
significantly higher reported physical 
symptoms that emotional symptoms 
(p=0.001) 
Regular screening has 
greater benefit than 
infrequent screening 
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Study Purpose Method/Tool Results Notes 
Zebrack et 
al., 2015  
Explores how well distress 
protocols have been 
implemented into practice in 
two cancer centers 
Retrospective examination of medical 
records (n=194) over a period of one 
year. 
43-73% of patients who should have 
met screening criteria received 
screening.  Appropriate referral was 
made and documented 50-63 % of the 
time. 
Author infers that 
insufficient resources for 
follow up may have 
accounted for lack of 
referral documentation (p 
1168). 
Variability also attributed 
to length of time since the 
protocols had been 
introduced into the 
practice setting (only a 
few years in one of the 
centers) and availability 
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1005 
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of abstract 
61 
Full text accessed/reviewed 
77 
Excluded following review 
of full text 
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of psychosocial screening 
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 Pediatric / 
Adolescent 
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 No assessment 
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New Screening Tools 
Identified from Search 
 0 
Tools Identified: 50 
 
Tools selected 
HADS & PHQ 
Excluded following 










Summary of Reviews of Psychometric Screening Tools Beyond Oncology 
Study Pertinent Tools Presented 
Population Assessed – 
Domain Measured 
Results 
Bjӧrn et al., 2014 BAI, CES-D, HADS, HrQOL, NIH-
CPSI, PHQ-9, SF-12, SF-36, PSS 
 
Chronic Prostatitis/Chronic 
Pelvic Pain Syndrome – 
psychiatric comorbidity and 
social factors 
An association between both depression and anxiety and 
increased report of chronic pain was appreciated in the 
literature.  Only 5 of 69 articles reviewed measured the 
effect of stress as a psychosocial factor specifically - Ahn et 
al. (2012), Anderson et al. (2009). Anderson et al. (2008), 
Aubin et al. (2008), and Ulrich et al. (2005).  PHQ-9 was 
not used in any of those articles. HADS was used in one 
article (Ahn, 2012). 
 
Cagle et al., 2017 GAD-7, KCCQ, MLHF. PHQ-9, 
POMS 
 
Heart Failure – anxiety and 
depression; quality of life 
(QoL) 
Patients with HF have increased emotional needs related to 
feeling heightened spiritual distress, dissonance regarding 
perspective of meaning of life, and abandonment.  The 
authors encourage increased palliative care models and 
intervention, similar to those in oncology, to reduce distress 
and increase QoL in the HF population 
 
Crawshaw et al., 2016 BDI, BMQ-specific, SCL-90-R, 
HADS, PHQ-9 
 
Acute Coronary Syndrome 
and Medication Adherence 
– anxiety and depression; 
psychosocial predictors 
An association between psychosocial variables and 
medication adherence was appreciated.  Depression and 
Type D personality were found to have significant effect on 
adherence.  The authors recommend routine screening for 
these patients.  Other pertinent factors included patient 
perspective of treatments and cognition. 
 
Croicu et al., 2014 BATHE, DSM-5, GAD-7, PHQ-9 
 
Patients with multiple 
somatic complaints – 
anxiety and depression; 
psychologic factors 
Anxiety and depression contribute to somatic symptoms.  
Screening should be done and followed-up upon.  No 
specific tool is endorsed for screening 
 
Dansie & Turk, 2013 ACT-UP, CSQ, BDI, POMS, SCL-
90R, PCS 
 
Chronic Pain The biomedical, psychosocial and behavioral domains must 




Study Pertinent Tools Presented 
Population Assessed – 
Domain Measured 
Results 
Duerinckx et al., 2014 ACSA, ALL, ASI, BDI, BMQ, 
COPE, DAST, FKV, GAD-7, GBB, 
HSCL, MAST, MMPI, MOS, MSE, 
NI, PAS, PHQ, PSQ, SCL-90-R, SF-
36, TERS, WAIS, WHOWOL 
 “Self-rating Anxiety Scale” 
TX Center 22 (unpublished)  
 
Living kidney and liver 
donor candidates – 
psychosocial screening for 
suitability to donate 
No standardized definition of “psychosocial” or 
methodology for screening exists in this population.  
Uniform practices with standardized terminology and 
assessment tool are needed.  Call for cohort studies to 
identify predictable risk factors toward the development of 
evidence-based guidelines is warranted. 
Feinstein et al., 2014 BDI-II, DSM-5, HADS 
Beck Fast Screen for Medically Ill 
Patients 
Yale Single Question Screen for 
Depression 
 
Multiple Sclerosis - 
Depression 
Higher rates of depression are associated with Multiple 
Sclerosis. Though BDI was endorsed by the American 
Academy of Neurology, HADS and Beck Fast Screen are 
valid alternatives.  HADS is able to detect anxiety as well 
as depression, which occurs in approximately 50% of 
patients with MS and contributes to increased morbidity.  
Patient reported chronic pain is also strongly associated 
with depression.  Interventions focused on the source of 
stress and coping are more beneficial than those that target 
emotion and avoidance. 
 
Ferro, Caeiro, & 
Figeira, 2016 
BDI, DSM-V(GAD), HADS, HDRS, 
IES, MADRS, 
Clinical Diagnostic Interviews 
Stroke Patients – 
neuropsychiatric disorders, 
anxiety 
Among stroke survivors, one-third to one-half will be 
affected by a neuropsychiatric disorder.  Early detection 
and treatment is beneficial.  Use of multiple scales has 
clouded the ability to effectively evaluate and distinguish 
minor disturbances from true psychiatric disorders.  Region 
of the brain affected by stroke was not definitively 
associated with psychiatric sequelae on a consistent basis.  
Tests on cerebrospinal fluid composition have, as yet, been 
inconclusive toward predicting psychiatric disorders 
following stroke. 
 
Kyong Suk, 2017 PHQ-2, PHQ-9 HF - Depression Patients positive depression scores on PHQ-2 and PHQ-9 
had 53% and 60% greater risk, respectively, for all-cause 
death than patients with negative depression scores 
33 
Study Pertinent Tools Presented 
Population Assessed – 
Domain Measured 
Results 
Lai et al., 2016 “Psychometric Tests” 
BDI, CED-D, DSM IV, ES-Q, GHQ-
12, GHQ, HADS, HDRS, MADRS 
 
Vitiligo - Depression Prevalence of depression in patients with vitiligo was 
significant and was dependent on tool used to screen or 
possibly location.  These patients should be screened and 
provided follow-up should depression be detected.  No 
scale, in particular, was recommended above any other for 




& Souza, 2016 
CAE, GAD-7, SDS, STAI, HADS 
 
Genetic Generalized 
Epilepsy – Psychologic and 
Psychosocial Comorbidities 
Psychologic and psychosocial comorbidities tend to 
decrease over time, but result is not conclusive secondary to 
the variability in assessment techniques and tools.   
Nanni et al., 2015 BDI, CES-D. K10, PHQ-9 
 
HIV - Depression Depression affects as much as 42% of patients with HIV, as 
much as four-fold increase compared individuals who are 
not infected.  Incorporation of screening and managing 
depression are necessary.  Validated screening tools, such 
as PHQ and CES-D are all suitable to use with this 
population. 
 
Pogosova et al.,2014 CIDI, ESSSI, HADS, PHQ-9, STAI 
Hollingshead two-factor index of 
social position 
 
Cardiac Rehab – 
Psychosocial factors 
Psychosocial risk factors, used synonymously with 
psychological stress, include social environment, 
characteristics of personality, and negative affect.  
Depression and anxiety, in particular, have the highest 
impact of psychosocial risk factors on cardiac 
rehabilitation, contributing to an approximate two-fold risk 
(1.6-2.2) increase for negative cardiac outcomes and higher 
program dropout rates.  HADS and PHQ are the most 
widely used screening tools used to detect depression. 
 
Van der Heijden, 
Abrahams, & Sinclair 
(2017) 
BDI, CES-D. HADS, IES, POMS, 
PSS, STAI 
HIV – Psychological Well-
being 
In patients with HIV, group-based therapies based on 
cognitive behavioral therapy (CBT) may have a small effect 
on depression for a little over one year (15 months), but 
those based on mindfulness had not demonstrable effect.  
Neither intervention showed much effect on anxiety, 
coping, or stress. 
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Study Pertinent Tools Presented 
Population Assessed – 
Domain Measured 
Results 
Younge, et al. (2014) CES-D, GWB, HADS, MLHFQ, SF-
36, STAI, WHOQOL 
Cardiac Disease – Stress 
management 
In the studies reviewed, Mind-body practices showed small 
to moderate significance on QoL, Depression, Anxiety, and 
Blood Pressure.  Depression was rated with CES-D and 
HADS; Anxiety was rated with CES-D, HADS, GWB, and 
STAI. 
 
List of Psychometric Tools Abbreviations 
ACSA - Anamnestic Comparison Self-Assessment Scale 
ACT-UP - Activity, Coping, Think, Upset, People’s responses Interview Method 
ALL – Altagsfragebogen, 
ASI – Addiction Severity Index 
BAI - Beck Anxiety Inventory 
BDI - Beck Depression Inventory 
BSI - Brief Symptom inventory 
BMQ – Berlin Mood Questionnaire 
CES-D - Center for Epidemiological Studies Depression Scale 
CIDI – Composite International Diagnostic Interview 
COPE - Coping Orientation to Problems Experienced Inventory 
CSQ – College Sleep Questionnaire 
DRS – Decision Regret Scale 
DAST – Drug Abuse Screening Tool 
ESSSI - ENRICHD Social Support Inventory 
ES-Q – Experience of Service Questionnaire 
FKV - Frieburg Illness-Coping Questionnaire 
HADS - Hospital Anxiety and Depression Scale 
HDRS – Hamilton Depression Rating Scale 
GAD-7 - Generalized Anxiety Disorder-7 
GBB – Giessen Complaint Questionnaire 
GHQ - General Health Questionnaire 
GWB – General Well Being, HSCL 
Hopkins Symptom Checklist, SCL-90-R- Global Distress Subscale 
IES – Impact of Events Scale 
KCCQ - KC Cardiomyopathy Questionnaire 
 
K10 – Kessler Psychological Distress Scale 
MADRS – Montgomery and Ǻsberg Depression Rating Scale 
MAST, Michigan Alcohol Screen Tool 
MLHFQ – Minnesota Living with Health Failure 
MMPI – Minnesota Multiphasic Personality Inventory 
MOS – Medical Outcomes Survey Social Support Survey 
MSE – Brief Mental Status Exam 
NI – Narcissism Inventory 
NIH-CPSI – National Institutes of Health Chronic Prostatitis Symptom Index 
PAS – Perceived Available Support 
PCS – Pain Catastrophizing Scale 
PHQ-9 - Patient Health Questionnaire 
POMS - Profile of Mood States 
PSQ – Perceived Stress Questionnaire 
PSS - Perceived Stress Scale 
SCL-90-R – Symptom Checklist 90 Revised 
SDS - Self-Rated Depressive Scale 
SF-36 - 36-Item Short Form Health Survey 
SRQ-20 – Self Reported Questionnaire 
STAI - State-Trait Anxiety Inventory 
SWOP – Self-Efficacy Optimism and Pessimism Questionnaire (Selbstwirksamkeit 
Optimismus, Pessimismus) 
TERS, Transplant Evaluation Rating Scale 
WAIS – Wechsler Adult Intelligence Scale 
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Literature Comparing HADS and DT 
Study Purpose Method Results Theme 
Boyes et al., , 2013 Comparison of DT to 
HADS in detecting 
psychological morbidity in 
cancer survivors? 
Cross-sectional survey of 
adult cancer survivors (n = 
1,323) were assessed with 
HADS and DT at 6 months 
after diagnosis 
DT was able to distinguish between HADS 
determinant cases and non-cases (AUC 
0.84-0.87). 
DT Cut-off determined at >2 for clinical 
setting and >4 in research setting; 
comparable to HADS ≥ 8 
 
DT is comparable to 
HADS and PHQ 
Bidstrup et al., 2012 Test the accuracy of the 
Dutch version of the DT 
by comparing to HADS 
A sample of 357 breast 
cancer patients were assessed 
with DT and HADS over a 
one-year period 
 
DT performance was comparable to HADS 
Cut-off of 2-3 was optimal, with rating of 
6 and 7 indicating moderate to severe 
distress, respectively. 
 
DT is comparable to 
HADS and PHQ 
Butow et al., 2015 Establish an evidence-
based plan for screening 
for anxiety and depression 
in adult cancer patients in 
Australia 
Literature review for existing 
guidelines and systematic 
reviews and meta-analyses.  
There was also an advisory 
board and formalized process 
for stakeholder collaboration 
with 87 stakeholders. 
Professional roles were defined for 
clinicians 
Two-step screening – with DT or similar, 
and followed-up with HADS. 
Clinical staff should be aware of signs of 
anxiety and depression.  If screening yields 
a positive result, then referral for a more 
in-depth assessment should be made 
 
Lack of Standardization 
– this article addressed 
that 
Castelli et al., 2015 determine if the stress 
response in the brain is 
consistent with DT and 
HADS screening results 
DT and HADS assessment 
along with PET brain glucose 
metabolism was analyzed in a 
sample of 21cancer patients. 
 
DT scores showed correlation with 
expected areas of the brain’s response to 
stress, while HADS was more diffuse, 
including the limbic system and cortex.  
Increased hypothalamus metabolism was 





Study Purpose Method Results Theme 
Lambert et al., 2014 Validate cut-off scores 
between HADS and DT 
Use HADS scores to detect 
DT cut-off score using Rasch 
analysis (n = 340) 
Distinction between standard correlation of 
HADS ≥ 8 and DT ≥ 4 if DT is used as a 
solitary screening tool.  These authors 
recommend a cut-off of DT 6 or seven if 
used as a sole screening method. 
DT ≥ 4 is appropriate if follow-up 
screening is implemented 
 
DT is comparable to 
HADS and PHQ 
 
Lack of standardization 
– psychometric scales 
often require adjustment 
in culture and contexts 
 
Patel et al., 2011 Evaluate sensitivity, 
specificity, and optimal 
cut-off scores for screening 
with HADS and DT when 
compared clinical 
interviews. 
A sample of 99 patients with 
colorectal cancer completed 
screening with HADS and 
DT. ROC analysis was 
performed on the screening 
scores and then compared 
with the sample of 17 patients 
that had been referred for 
clinical diagnostic interviews 
 
Neither HADS nor DT outperformed the 
diagnostic clinical interview for 
diagnosing … 
DT is comparable to 
HADS and PHQ 
 
Neither HADS nor DT 
showed good ability to 
identify anxiety 
disorders in this study 
Schellekens et al., 
2016 
Explore the suitability of 
HADS, DT, Beck 
Depression Inventory 
(BDI-II), and State 
subscale of State Trait 
Anxiety Inventory (STAI-
S) to screen for psychiatric 
disorders in patients with 
lung cancer and also their 
partners 
 
A sample of 144 patients 
were assessed with the 
screening tools, and then 
participated in the Structured 
Clinical Interview DSM-IV 
SCID-I 
DT is suitable for screening of general 
distress, and not for screening of 
psychiatric disorders.  HADS total score 
performed better than DT for screening of 
psychiatric disorders, but as a first-step 
tool only. 
DT is comparable to 
HADS and PHQ 
(exception – diagnosis of 
psychiatric disorders) 
 
DT captures broader 
scope of psychological 
stressors 
 
Lack of standardization 
Wang et al., 2011 Validation of the DT and 
HADS in Taiwanese 
patients with cancer 
DT and HADS tools were 
used to assess a sample of 
103 patients over a 7-month 
period in 2004.   
DT outperformed HADS in sensitivity and 
specificity, though either tool is 
appropriate to assess the target patient 
population. 
Cut-offs were determined as ≥4 for DT and 
≥ 8 for HADS subscales.   
DT is comparable to 




Literature Comparing PHQ and DT 
 
Study Purpose Method Results Theme 




of need and relate 
need for psychosocial 




Cross-Sectional (n = 4,020) 
Patients completed DT and 
PHQ, then a subset (n = 2,141) 
were evaluated with the 
Composite International 
Diagnostic Interview (CIDI) 
Half of those with higher scores on DT and PHQ 
similarly perceived need for psychosocial support.  
Authors infer that patients’ expectation of a certain 
level of distress may have influenced perception of 
need.  About one-quarter of those with lower scores 
on DT and PHQ still perceived need for psychosocial 
support.  All measures performed similarly.  Both DT 
and PHQ independently and collectively significantly 
predicted perception of need.  
 
DT is Comparable to 
PHQ and HADS 
 
Patients like DT: Fewer 
patients declined to 
complete DT and PHQ 
than those who refused 
CIDI 
Hegel et al., 
2008 
Assess the validity of 
DT compared with 
PHQ in assessing for 
depression 
Over a period of 30 months, a 
sample of 321 newly diagnosed 
breast cancer patients (stages I-
III) completed the DT and then 
PHQ assessments.  These were 
analyzed with ROC 
DT achieved AUC for specificity of 0.85 with a cut-
off of 7 
DT is Comparable to 
PHQ and HADS 
 
A positive screen for DT 
may need follow-up with 





Determine if DT is 
able to assess for 
depression accurately 
in a population of 
patients with 
advanced cancer 
A cross-sectional sample of 123 
patients within 30 days of 
diagnosis were assessed using 
the DT and the PHQ-2.  ROC 
analysis was performed 
DT cut-off score of ≥2 was more sensitive for 
detecting depression PHQ-2 (≥2).  Sensitivity was 
0.92 for DT, and 0.32 for the PHQ-2.  DT ≥2 agreed 
with PHQ-9 ≥5, detecting 39 more cases of depression 
than the PHQ-2.  Agreement with problems 1-4 in the 
Emotional Domain can be used for triage for referral. 
 
DT is Comparable to 
PHQ and HADS 
 
DT captures broader 
scope than HADS or PHQ 
Wagner et 
al., 2017 
Evaluate brief tools 
for screening for 
depression in cancer 
patients in an 
outpatient setting 
A sample of 455 cancer patients 
were assessed with PHQ-2, 
PHQ-9, DT, and HSCL-25.  
Scores exceeding cut-offs were 
referred to clinical interview 
via telephone  
DT specificity was 0.52, and sensitivity of 0.80 
PHQ-9 specificity was 0.69, and sensitivity of 0.79 
PHQ-2 specificity was 0.63, and sensitivity of 0.86 
PHQ-9 was accurate to detect cases (AUC 0.85) 
PHQ-2 was also accurate (AUC 0.83)  
The HSCL-25 performed fairly (AUC 0.80)  
DT was poor to detect mood disorders (AUC 0.59) 
DT is Comparable to 
PHQ and HADS 
 
Does not perform well to 
detect mood disorders 
39 
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